Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study

INTRODUCTION: The dynamic range of cerebrospinal fluid (CSF) amyloid β (Aβ(1–42)) measurement does not parallel to cognitive changes in Alzheimer's disease (AD) and cognitively normal (CN) subjects across different studies. Therefore, identifying novel proteins to characterize symptomatic AD sa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (Amst)
Main Authors: Leung, Yuk Yee, Toledo, Jon B., Nefedov, Alexey, Polikar, Robi, Raghavan, Nandini, Xie, Sharon X., Farnum, Michael, Schultz, Tim, Baek, Young, Van Deerlin, Vivianna M., Hu, William T., Holtzman, David M., Fagan, Anne M., Perrin, Richard J., Grossman, Murray, Soares, Holly D., Kling, Mitchel A., Mailman, Matthew, Arnold, Steven E., Narayan, Vaibhav A., Lee, Virginia M-Y., Shaw, Leslie M., Baker, David, Wittenberg, Gayle M., Trojanowski, John Q., Wang, Li-San
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2015
Assuntos:
CSF Biomarkers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4672388/
https://ncbi.nlm.nih.gov/pubmed/26693175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.06.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados